Holding(s) in Company

AI SummaryClose X

Rathbones Investment Management Ltd reported on 12-Nov-2026 that its holding in Fusion Antibodies fell to 5,989,374 shares, representing 4.7855% of voting rights as of 11-Nov-2026 (down from a prior 7.7425%), a reduction of 2.9570 percentage points; no voting rights are held via financial instruments (0.0000%), and the change was notified as an acquisition or disposal of voting rights.

Disclaimer*

UK 100

Latest directors dealings